Vollständiger Abstract
Worum geht es in dieser Arbeit?
Study Design: Retrospective cohort study. Introduction: Cell saver (CS) is widely used in spinal fusion to reduce exposure to allogeneic transfusion, which carries risks such as infection and prolonged hospitalization. Pediatric spinal fusion is frequently associated with significant intraoperative blood loss. Concerns persist that reinfused blood could increase morbidity. We therefore evaluated the association between CS exposure and postoperative outcomes after pediatric spinal fusion using the American College of Surgeons National Surgical Quality Improvement Program Pediatric database. Methods: Among patients who underwent spinal fusion surgery for pediatric spinal deformity between 2021 and 2023, CS exposure was categorized as none, low (
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Daniel A. Ortega, Yaxel Levin-Carrion, Justin L. Reyes, Elisabeth Geraghty, Ted Shi, Hannah Peterson, Takera Purdie, Daysha Fliginger, Lawrence G. Lenke, Joseph M. Lombardi, Lisa Eisler, Zeeshan M. Sardar
- Quelle
- Journal of Pediatric Orthopaedics
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 0271-6798, 1539-2570
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Daniel A. Ortega, Yaxel Levin-Carrion, Justin L. Reyes, Elisabeth Geraghty, Ted Shi, Hannah Peterson, Takera Purdie, Daysha Fliginger, Lawrence G. Lenke, Joseph M. Lombardi, Lisa Eisler, Zeeshan M. Sardar (2026). Cell Saver Use is Not Associated With Increased Morbidity But Reflects Transfusion Burden in Pediatric Spinal Deformity Surgery: A Retrospective Cohort Study. Journal of Pediatric Orthopaedics. https://doi.org/10.1097/bpo.0000000000003450